UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy

European heart journal, 1999-09, Vol.20 (18), p.1342-1354

1999

Volltextzugriff (PDF)

Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients

Heart (British Cardiac Society), 2004-06, Vol.90 (6), p.638-644

2004

Volltextzugriff (PDF)

Determination of Success of Transcoronary Ablation of Septum Hypertrophy in Patients with Hypertrophic Obstructive Cardiomyopathy by Perfusion Echocardiography

Ultrasound in medicine & biology, 2011, Vol.37 (8), p.S110-S110

2011

Volltextzugriff (PDF)

Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy : Studies to develop a new catheter-based concept of treatment

European heart journal, 1997-05, Vol.18 (5), p.846-851

1997

Volltextzugriff (PDF)

Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion

European heart journal, 1999-12, Vol.20 (24), p.1808-1817

1999

Volltextzugriff (PDF)

Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle

The Journal of biological chemistry, 1998-06, Vol.273 (26), p.15980

1998

Volltextzugriff (PDF)

Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillation

Clinical research in cardiology, 2006-05, Vol.95 (5), p.254-260

2006

Volltextzugriff (PDF)

Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The cardiomyopathy trial (CAT)

Circulation (New York, N.Y.), 2002-03, Vol.105 (12), p.1453-1458

2002

Volltextzugriff (PDF)

Congenital anomalies of the coronary arteries: imaging with contrast-enhanced, multidetector computed tomography

European radiology, 2005-06, Vol.15 (6), p.1110-1121

2005

Volltextzugriff (PDF)

‘The abrupt no-flow’: a no-reflow like phenomenon in hypertrophic cardiomyopathy

European heart journal, 2002-01, Vol.23 (1), p.91-93

2002

Volltextzugriff (PDF)

Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures

The American heart journal, 2009-11, Vol.158 (5), p.822-828.e3

2009

Volltextzugriff (PDF)

Epikardiale Ablation ventrikulärer Tachykardien

Herzschrittmachertherapie & Elektrophysiologie, 2017-06, Vol.28 (2), p.212-218

2017

Volltextzugriff (PDF)

Autoinhibition of Casein Kinase I ε (CKIε) Is Relieved by Protein Phosphatases and Limited Proteolysis

The Journal of biological chemistry, 1998-01, Vol.273 (3), p.1357-1364

1998

Volltextzugriff (PDF)

Herztransplantation: Indikation und präoperative Betreuung

Zeitschrift für Herz-, Thorax- und Gefässchirurgie, 2004-09, Vol.18 (S1), p.i1-i5

2004

Volltextzugriff (PDF)

Catheter interventional septal abiation for hypertrophic obstructive cardiomyopathy: an analysis of the follow-up data from the registry of the german society of cardiology

Journal of the American College of Cardiology, 2002-03, Vol.39, p.3-3

2002

Volltextzugriff (PDF)

A reply

European heart journal, 2000-04, Vol.21 (7), p.591-593

Gietzen, F

2000

Volltextzugriff (PDF)

Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy

Clinical research in cardiology, 2000-04, Vol.89 Suppl 4 (16), p.IV41-IV54

2000

Volltextzugriff (PDF)

Epicardial ablation of ventricular tachycardias

Herzschrittmachertherapie & Elektrophysiologie, 2017-06, Vol.28 (2), p.212-218

2017

Volltextzugriff (PDF)

Interventional treatment in hypertrophic cardiomyopathy

Herz, 2005-03, Vol.30 (2), p.102-110

2005

Volltextzugriff (PDF)

Transcoronary ablation of septal hypertrophy (TASH): supersedes it the surgery (myectomy)?

Herz, 1999-12, Vol.24 (8), p.647-651

1999

Volltextzugriff (PDF)

Acute and Long-term Results After Transcoronary Ablation of Septum Hypertrophy in Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 1998-02, Vol.31 (2), p.182-183A

Gietzen, F

1998

Volltextzugriff (PDF)

Definition and classification of cardiomyopathies

Circulation (New York, N.Y.), 1996-12, Vol.94 (11), p.2991-2992

1996

Volltextzugriff (PDF)

Catheter-based septalablation for symptomatic hypertrophic obstructive cardiomyopathy

Clinical research in cardiology, 2005-08, Vol.94 (8), p.516-523

2005

Volltextzugriff (PDF)

Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions

Circulation (New York, N.Y.), 2002-07, Vol.106 (4), p.454-459

2002

Volltextzugriff (PDF)

Identification of Inhibitory Autophosphorylation Sites in Casein Kinase I ε

The Journal of biological chemistry, 1999-11, Vol.274 (45), p.32063-32070

1999

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(83)

Sprache

Englisch
(69)
Deutsch
(16)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(44)
Humans
(40)
Male
(36)
Biological And Medical Sciences
(23)
Female
(22)
Cardiac & Cardiovascular Systems
(21)
Cardiovascular System & Cardiology
(21)
Middle Aged
(20)
Adult
(18)
Animals
(16)
Rats
(16)
Aged
(14)
Medical Sciences
(13)
Cardiomyopathy, Hypertrophic - Therapy
(11)
Diet
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Rats, Sprague-Dawley
(10)
Treatment Outcome
(10)
Cardiology. Vascular System
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy

Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients

Determination of Success of Transcoronary Ablation of Septum Hypertrophy in Patients with Hypertrophic Obstructive Cardiomyopathy by Perfusion Echocardiography

Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy : Studies to develop a new catheter-based concept of treatment

Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion

Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle

Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillation

Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The cardiomyopathy trial (CAT)

Congenital anomalies of the coronary arteries: imaging with contrast-enhanced, multidetector computed tomography

‘The abrupt no-flow’: a no-reflow like phenomenon in hypertrophic cardiomyopathy

Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures

Epikardiale Ablation ventrikulärer Tachykardien

Autoinhibition of Casein Kinase I ε (CKIε) Is Relieved by Protein Phosphatases and Limited Proteolysis

Herztransplantation: Indikation und präoperative Betreuung

Catheter interventional septal abiation for hypertrophic obstructive cardiomyopathy: an analysis of the follow-up data from the registry of the german society of cardiology

A reply

Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy

Epicardial ablation of ventricular tachycardias

Interventional treatment in hypertrophic cardiomyopathy

Transcoronary ablation of septal hypertrophy (TASH): supersedes it the surgery (myectomy)?

Acute and Long-term Results After Transcoronary Ablation of Septum Hypertrophy in Hypertrophic Cardiomyopathy

Definition and classification of cardiomyopathies

Catheter-based septalablation for symptomatic hypertrophic obstructive cardiomyopathy

Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions

Identification of Inhibitory Autophosphorylation Sites in Casein Kinase I ε

Suchergebnisse filtern